Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial. [PDF]
Liu X +9 more
europepmc +1 more source
Comparison of Intralesional Measles, Mumps, Rubella Vaccine and Needling in the Treatment of Recurrent Warts. [PDF]
Kolte SR, Sardesai VR.
europepmc +1 more source
Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. [PDF]
Quach HQ +5 more
europepmc +1 more source
Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc +1 more source
Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]
Ratta BS, Naik A, Mutha S.
europepmc +1 more source
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine. [PDF]
Crooke SN +4 more
europepmc +1 more source
A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc +1 more source
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]
Saha S +11 more
europepmc +1 more source

